Artículos de revistas sobre el tema "ATP-competitive"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "ATP-competitive".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Lebakken, Connie S., Laurie J. Reichling, Jason M. Ellefson y Steven M. Riddle. "Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes". Journal of Biomolecular Screening 17, n.º 6 (26 de marzo de 2012): 813–21. http://dx.doi.org/10.1177/1087057112439889.
Texto completoAgius, Michael P., Kristin Ko, Taylor K. Johnson, Sameer Phadke y Matthew B. Soellner. "Conformation-tunable ATP-competitive kinase inhibitors". Chemical Communications 58, n.º 21 (2022): 3541–44. http://dx.doi.org/10.1039/d1cc06893h.
Texto completoGaruti, L., M. Roberti y G. Bottegoni. "Non-ATP Competitive Protein Kinase Inhibitors". Current Medicinal Chemistry 17, n.º 25 (1 de septiembre de 2010): 2804–21. http://dx.doi.org/10.2174/092986710791859333.
Texto completoLee, Byung-Il, Hyung-Jun Ahn, Ki-Cheol Han, Dae-Ro Ahn y Dong-Yun Shin. "Pyrogallin, an ATP-Competitive Inhibitor of JAK3". Bulletin of the Korean Chemical Society 32, n.º 3 (20 de marzo de 2011): 1077–79. http://dx.doi.org/10.5012/bkcs.2011.32.3.1077.
Texto completoSchenone, S., C. Brullo, F. Musumeci, M. Radi y M. Botta. "ATP-Competitive Inhibitors of mTOR: An Update". Current Medicinal Chemistry 18, n.º 20 (1 de julio de 2011): 2995–3014. http://dx.doi.org/10.2174/092986711796391651.
Texto completoLazaro, Glorianne, Eleftherios Kostaras y Igor Vivanco. "Inhibitors in AKTion: ATP-competitive vs allosteric". Biochemical Society Transactions 48, n.º 3 (26 de mayo de 2020): 933–43. http://dx.doi.org/10.1042/bst20190777.
Texto completoParrish, Cynthia A., Nicholas D. Adams, Kurt R. Auger, Joelle L. Burgess, Jeffrey D. Carson, Amita M. Chaudhari, Robert A. Copeland et al. "Novel ATP-Competitive Kinesin Spindle Protein Inhibitors". Journal of Medicinal Chemistry 50, n.º 20 (octubre de 2007): 4939–52. http://dx.doi.org/10.1021/jm070435y.
Texto completoIto, Masahiro, Misa Iwatani, Yusuke Kamada, Satoshi Sogabe, Shoichi Nakao, Toshio Tanaka, Tomohiro Kawamoto, Samuel Aparicio, Atsushi Nakanishi y Yasuhiro Imaeda. "Discovery of selective ATP-competitive eIF4A3 inhibitors". Bioorganic & Medicinal Chemistry 25, n.º 7 (abril de 2017): 2200–2209. http://dx.doi.org/10.1016/j.bmc.2017.02.035.
Texto completoZarębska, Ewa A., Krzysztof Kusy, Ewa M. Słomińska, Łukasz Kruszyna y Jacek Zieliński. "Plasma Nucleotide Dynamics during Exercise and Recovery in Highly Trained Athletes and Recreationally Active Individuals". BioMed Research International 2018 (9 de octubre de 2018): 1–11. http://dx.doi.org/10.1155/2018/4081802.
Texto completoLyle, S., D. H. Geller, K. Ng, J. Stanczak, J. Westley y N. B. Schwartz. "Kinetic mechanism of adenosine 5′-phosphosulphate kinase from rat chondrosarcoma". Biochemical Journal 301, n.º 2 (15 de julio de 1994): 355–59. http://dx.doi.org/10.1042/bj3010355.
Texto completoTakahashi, Hideyuki y Hideo Namiki. "Mechanism of membrane redistribution of protein kinase C by its ATP-competitive inhibitors". Biochemical Journal 405, n.º 2 (27 de junio de 2007): 331–40. http://dx.doi.org/10.1042/bj20070299.
Texto completoQuartieri, Francesca, Marcella Nesi, Nilla R. Avanzi, Daniela Borghi, Elena Casale, Emiliana Corti, Ulisse Cucchi et al. "Identification of unprecedented ATP-competitive choline kinase inhibitors". Bioorganic & Medicinal Chemistry Letters 51 (noviembre de 2021): 128310. http://dx.doi.org/10.1016/j.bmcl.2021.128310.
Texto completoTang, Colin P., Owen Clark, John R. Ferrarone, Carl Campos, Alshad S. Lalani, John D. Chodera, Andrew M. Intlekofer, Olivier Elemento y Ingo K. Mellinghoff. "GCN2 kinase activation by ATP-competitive kinase inhibitors". Nature Chemical Biology 18, n.º 2 (23 de diciembre de 2021): 207–15. http://dx.doi.org/10.1038/s41589-021-00947-8.
Texto completoFreeman-Cook, Kevin D., Christopher Autry, Gary Borzillo, Deborah Gordon, Elsa Barbacci-Tobin, Vincent Bernardo, David Briere et al. "Design of Selective, ATP-Competitive Inhibitors of Akt". Journal of Medicinal Chemistry 53, n.º 12 (24 de junio de 2010): 4615–22. http://dx.doi.org/10.1021/jm1003842.
Texto completoTunnicliff, G. y T. L. Youngs. "Competitive Inhibition of Mouse Brain -Aminobutyrate Aminotransferase by ATP". Experimental Biology and Medicine 192, n.º 1 (1 de octubre de 1989): 11–15. http://dx.doi.org/10.3181/00379727-192-42947.
Texto completoPapa, F. R. "Bypassing a Kinase Activity with an ATP-Competitive Drug". Science 302, n.º 5650 (28 de noviembre de 2003): 1533–37. http://dx.doi.org/10.1126/science.1090031.
Texto completoHuck, Bayard R. y Igor Mochalkin. "Recent progress towards clinically relevant ATP-competitive Akt inhibitors". Bioorganic & Medicinal Chemistry Letters 27, n.º 13 (julio de 2017): 2838–48. http://dx.doi.org/10.1016/j.bmcl.2017.04.090.
Texto completoQuintás-Cardama, A. "Experimental non-ATP-competitive therapies for chronic myelogenous leukemia". Leukemia 22, n.º 5 (6 de marzo de 2008): 932–40. http://dx.doi.org/10.1038/leu.2008.47.
Texto completoBarf, Tjeerd, Allard Kaptein, Sander de Wilde, Ruud van der Heijden, Richard van Someren, Dennis Demont, Carsten Schultz-Fademrecht et al. "Structure-based lead identification of ATP-competitive MK2 inhibitors". Bioorganic & Medicinal Chemistry Letters 21, n.º 12 (junio de 2011): 3818–22. http://dx.doi.org/10.1016/j.bmcl.2011.04.018.
Texto completoZhang, Dingwa, Deyong He, Xiaoliang Pan y Lijun Liu. "Systematic profiling of ATP response to acquired drug-resistant EGFR family kinase mutations". Journal of the Serbian Chemical Society 85, n.º 10 (2020): 1265–78. http://dx.doi.org/10.2298/jsc191124028z.
Texto completoPinzi, Luca. "On the development of B-Raf inhibitors acting through innovative mechanisms". F1000Research 11 (26 de abril de 2022): 237. http://dx.doi.org/10.12688/f1000research.108761.2.
Texto completoPinzi, Luca. "On the development of B-Raf inhibitors acting through innovative mechanisms". F1000Research 11 (26 de abril de 2022): 237. http://dx.doi.org/10.12688/f1000research.108761.2.
Texto completoPinzi, Luca. "On the development of B-Raf inhibitors acting through innovative mechanisms". F1000Research 11 (25 de febrero de 2022): 237. http://dx.doi.org/10.12688/f1000research.108761.1.
Texto completoWilson, Brice A. P., Muhammad S. Alam, Tad Guszczynski, Michal Jakob, Shilpa R. Shenoy, Carter A. Mitchell, Ekaterina I. Goncharova et al. "Discovery and Characterization of a Biologically Active Non–ATP-Competitive p38 MAP Kinase Inhibitor". Journal of Biomolecular Screening 21, n.º 3 (4 de noviembre de 2015): 277–89. http://dx.doi.org/10.1177/1087057115615518.
Texto completoKhandekar, Sanjay S., Bingbing Feng, Tracey Yi, Susan Chen, Nicholas Laping y Neal Bramson. "A Liquid Chromatography/Mass Spectrometry-Based Method for the Selection of ATP Competitive Kinase Inhibitors". Journal of Biomolecular Screening 10, n.º 5 (agosto de 2005): 447–55. http://dx.doi.org/10.1177/1087057105274846.
Texto completoChung, Vincent, Ling Wang, Margaret S. Fletcher, Erminia Massarelli, Karen L. Reckamp, Mihaela C. Cristea, Nikeeta Prajapati et al. "First-time in-human study of VMD-928, an allosteric and irreversible TrkA selective inhibitor, in patients with solid tumors or lymphoma." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): TPS3146. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps3146.
Texto completoSchenone, S., C. Brullo y M. Botta. "Small Molecules ATP-Competitive Inhibitors of FLT3: A Chemical Overview". Current Medicinal Chemistry 15, n.º 29 (1 de diciembre de 2008): 3113–32. http://dx.doi.org/10.2174/092986708786848613.
Texto completoMa, Bin, Doug Marcotte, Murugan Paramasivam, Klaus Michelsen, Ti Wang, Andrea Bertolotti-Ciarlet, John Howard Jones et al. "ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis". PLOS ONE 11, n.º 11 (10 de noviembre de 2016): e0165983. http://dx.doi.org/10.1371/journal.pone.0165983.
Texto completoKarni, Rotem, Sarit Mizrachi, Ella Reiss-Sklan, Aviv Gazit, Oded Livnah y Alexander Levitzki. "The pp60c-Src inhibitor PP1 is non-competitive against ATP". FEBS Letters 537, n.º 1-3 (29 de enero de 2003): 47–52. http://dx.doi.org/10.1016/s0014-5793(03)00069-3.
Texto completoShen, Guobing, Miaoqing Liu, Jianjun Lu y Tao Meng. "Practical synthesis of Vistusertib (AZD2014), an ATP competitive mTOR inhibitor". Tetrahedron Letters 60, n.º 52 (diciembre de 2019): 151333. http://dx.doi.org/10.1016/j.tetlet.2019.151333.
Texto completoWu, Ke, Jingzhi Pang, Dong Song, Ying Zhu, Congwen Wu, Tianqu Shao y Haifeng Chen. "Selectivity Mechanism of ATP-Competitive Inhibitors for PKB and PKA". Chemical Biology & Drug Design 86, n.º 1 (28 de noviembre de 2014): 9–18. http://dx.doi.org/10.1111/cbdd.12472.
Texto completoFreeman-Cook, Kevin D., Christopher Autry, Gary Borzillo, Deborah Gordon, Elsa Barbacci-Tobin, Vincent Bernardo, David Briere et al. "Corrections to Design of Selective, ATP-Competitive Inhibitors of Akt". Journal of Medicinal Chemistry 53, n.º 15 (12 de agosto de 2010): 5895. http://dx.doi.org/10.1021/jm100769x.
Texto completoGarc�a-Echeverr�a, Carlos, Peter Traxler y Dean B. Evans. "ATP site-directed competitive and irreversible inhibitors of protein kinases". Medicinal Research Reviews 20, n.º 1 (enero de 2000): 28–57. http://dx.doi.org/10.1002/(sici)1098-1128(200001)20:1<28::aid-med2>3.0.co;2-2.
Texto completoWang, Ruixiu y James E. Thompson. "Detection of ATP Competitive Protein Kinase Inhibition by Western Blotting". Analytical Biochemistry 299, n.º 1 (diciembre de 2001): 110–12. http://dx.doi.org/10.1006/abio.2001.5410.
Texto completoKirkland, Lindsay O. y Campbell McInnes. "Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics". Biochemical Pharmacology 77, n.º 10 (mayo de 2009): 1561–71. http://dx.doi.org/10.1016/j.bcp.2008.12.022.
Texto completoRosborough, Brian, Dàlia Raïch-Regué, Benjamin Matta, Keunwook Lee, Mark Boothby, Heth Turnquist y Angus Thomson. "Rapamycin-resistant mTORC1 restrains dendritic cell B7-H1 expression that requires IL-1β to enhance regulatory T cell induction (P1349)". Journal of Immunology 190, n.º 1_Supplement (1 de mayo de 2013): 63.27. http://dx.doi.org/10.4049/jimmunol.190.supp.63.27.
Texto completoRoulin, Didier, Nicolas Demartines y Olivier Dormond. "ATP-competitive inhibitors of mTOR: new perspectives in the treatment of renal cell carcinoma". Biochemical Society Transactions 39, n.º 2 (22 de marzo de 2011): 492–94. http://dx.doi.org/10.1042/bst0390492.
Texto completoLi, Chunqiong, Xuewen Zhang, Na Zhang, Yue Zhou, Guohui Sun, Lijiao Zhao y Rugang Zhong. "Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening". Molecules 25, n.º 1 (6 de enero de 2020): 237. http://dx.doi.org/10.3390/molecules25010237.
Texto completoO’Connor, Suzanne, Yann-Vaï Le Bihan, Isaac M. Westwood, Manjuan Liu, Oi Wei Mak, Gabriel Zazeri, Ana P. R. Povinelli et al. "Discovery and Characterization of a Cryptic Secondary Binding Site in the Molecular Chaperone HSP70". Molecules 27, n.º 3 (26 de enero de 2022): 817. http://dx.doi.org/10.3390/molecules27030817.
Texto completoXu, Jimin, Jing Ai, Sheng Liu, Xia Peng, Linqian Yu, Meiyu Geng y Fajun Nan. "Design and synthesis of 3,3′-biscoumarin-based c-Met inhibitors". Org. Biomol. Chem. 12, n.º 22 (2014): 3721–34. http://dx.doi.org/10.1039/c4ob00364k.
Texto completoNapoleon, John V., Sarbjit Singh, Sandeep Rana, Mourad Bendjennat, Vikas Kumar, Smitha Kizhake, Nicholas Y. Palermo, Michel M. Ouellette, Tom Huxford y Amarnath Natarajan. "Small molecule binding to inhibitor of nuclear factor kappa-B kinase subunit beta in an ATP non-competitive manner". Chemical Communications 57, n.º 38 (2021): 4678–81. http://dx.doi.org/10.1039/d1cc01245b.
Texto completoShapiro, Adam B., Helen Plant, Jarrod Walsh, Mark Sylvester, Jun Hu, Ning Gao, Stephania Livchak, Sharon Tentarelli y Jason Thresher. "Discovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening". Journal of Biomolecular Screening 19, n.º 8 (12 de mayo de 2014): 1137–46. http://dx.doi.org/10.1177/1087057114534981.
Texto completoKatari, Naresh Kumar, Rambabu Gundla, Phani Kumar Reddy, Anuradha Vanam, Aruna Talatam, Noboru Motohashi y Rao Gollapudi. "Molecular Docking Studies of Glabrene and Human Epidermal Growth Factor Receptor Kinase". INNOSC Theranostics and Pharmacological Sciences 4, n.º 1 (29 de abril de 2022): 38–49. http://dx.doi.org/10.36922/itps.v4i1.56.
Texto completoCuthbertson, Peter, Amal Elhage, Dena Al-Rifai, Reece A. Sophocleous, Ross J. Turner, Ashraf Aboelela, Hiwa Majed et al. "6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist". Biomolecules 12, n.º 9 (16 de septiembre de 2022): 1309. http://dx.doi.org/10.3390/biom12091309.
Texto completoMcArdell, J. E. C., C. J. Bruton y T. Atkinson. "The isolation of a peptide from the catalytic domain of Bacillus stearothermophilus tryptophyl-tRNA synthetase. The interaction of Brown MX-5BR with tyrosyl-tRNA synthetase". Biochemical Journal 243, n.º 3 (1 de mayo de 1987): 701–7. http://dx.doi.org/10.1042/bj2430701.
Texto completoPark, Seojeong, Soo-Yeon Hwang, Jaeho Shin, Hyunji Jo, Younghwa Na y Youngjoo Kwon. "A chromenone analog as an ATP-competitive, DNA non-intercalative topoisomerase II catalytic inhibitor with preferences toward the alpha isoform". Chemical Communications 55, n.º 85 (2019): 12857–60. http://dx.doi.org/10.1039/c9cc05524j.
Texto completoDeans, N. L., R. D. Allison y D. L. Purich. "Steady-state kinetic mechanism of bovine brain tubulin: tyrosine ligase". Biochemical Journal 286, n.º 1 (15 de agosto de 1992): 243–51. http://dx.doi.org/10.1042/bj2860243.
Texto completoCozza, Giorgio, Andrea Bortolato, Ernesto Menta, Ennio Cavalletti, Silvano Spinelli y Stefano Moro. "ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents". Anti-Cancer Agents in Medicinal Chemistry 9, n.º 7 (1 de septiembre de 2009): 778–86. http://dx.doi.org/10.2174/187152009789056930.
Texto completoPitman, Melissa R., Jason A. Powell, Carl Coolen, Paul A. B. Moretti, Julia R. Zebol, Duyen H. Pham, John W. Finnie et al. "A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties". Oncotarget 6, n.º 9 (11 de marzo de 2015): 7065–83. http://dx.doi.org/10.18632/oncotarget.3178.
Texto completoHornakova, T., L. Springuel, J. Devreux, A. Dusa, S. N. Constantinescu, L. Knoops y J. C. Renauld. "Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors". Haematologica 96, n.º 6 (10 de marzo de 2011): 845–53. http://dx.doi.org/10.3324/haematol.2010.036350.
Texto completo